Crohn's Disease - Thorne Research

ReviewCrohn’s Disease241. Lorenz R, Weber PC, Szimnau P, et al.Supplements with n-3 fatty acids from fish oilin chronic inflammatory bowel disease – arandomized, placebo-controlled, double-blindcross-over trial. J Intern Med 1989;225:225-232.242. Hillier K, Jewell R, Dorrell L, Smith CL.Incorporation of fatty acids from fish oil andolive oil into colonic mucosal lipids andeffects upon eicosanoid synthesis in inflammatorybowel disease. Gut 1991;32:1151-1155.243. Lorenz-Meyer H, Bauer P, Nicolay C, et al.Omega-3 fatty acids and low carbohydrate dietfor maintenance of remission in Crohn’sdisease. A randomized controlled multicentertrial. Study Group Members (German Crohn’sDisease Study Group). Scand J Gastroenterol1996;31:778-785.244. Belluzzi A, Brignola C, Campieri M, et al.Effect of an enteric-coated fish-oil preparationon relapses in Crohn’s disease. N Engl J Med1996;334:1557-1560.245. Arslan G, Brunborg LA, Froyland L, et al.Effects of duodenal seal oil administration inpatients with inflammatory bowel disease.Lipids 2002;37:935-940.246. Segain JP, de la Bletiere DR, Bourreille A, etal. Butyrate inhibit inflammatory responsesthrough NFkappaB inhibition: implications forCrohn’s disease. Gut 2000;47:397-403.247. Coeffier M, Marion R, Ducrotte P, DechelotteP. Modulating effect of glutamine in IL-1betainducedcytokine production by human gut.Clin Nutr 2003;22:407-413.248. Hond ED, Hiele M, Peeters M, et al. Effect oflong-term oral glutamine supplements on smallintestinal permeability in patients with Crohn’sdisease. JPEN J Parenter Enteral Nutr1999;23:7-11.249. Akobeng AK, Miller CV, Stanton J, et al.Double-blind randomized controlled trial ofglutamine-enriched polymeric diet in thetreatment of active Crohn’s disease. J PediatrGastroenterol Nutr 2000;30:78-84.250. Akobeng AK, Miller CV, Thomas AG,Richmond K. Glutamine supplementation andintestinal permeability in Crohn’s disease.JPEN J Parenter Enteral Nutr 2000;24:196.251. Akobeng AK, Miller CV, Hall CM, ThomasAG. Low serum concentrations of insulin-likegrowth factor-I in children with active Crohndisease. Scand J Gastroenterol 2002;12:1422-1427.252. Goodman MJ, Kent PW, Truelove SC.Glucosamine synthetase activity of the colonicmucosa in ulcerative colitis and Crohn’sdisease. Gut 1977;18:219-228.253. Salvatore S, Heuschkel R, Tomlin S, et al. Apilot study of N-acetylglucosamine, a nutritionalsubstrate for glycosaminoglycansynthesis, in paediatric chronic inflammatorybowel disease. Aliment Pharmacol Ther2000;14:1567-1579.254. Srinivasan P, Libbus B. Mining MEDLINE forimplicit links between dietary substances anddiseases. Bioinformatics 2004;20:1290-1296.255. Ammon HP, Mack T, Singh GB, Safayhi H.Inhibition of leukotriene B4 formation in ratperitoneal neutrophils by an ethanolic extractof the gum resin exudate of Boswellia serrata.Planta Med 1991;57:203-207.256. Gerhardt H, Seifert F, Buvari P, et al. Therapyof active Crohn disease with Boswellia serrataextract H 15. Z Gastroenterol 2001;39:11-17.[Article in German]257. Zhou H, Mineshita S. The effect of berberinechloride in experimental colitis in rats in vivoand in vitro. J Pharmacol Exp Ther2000;294:822-829.258. Straub RH, Vogl D, Gross V, et al. Associationof humoral markers of inflammation anddehydroepiandrosterone sulfate or cortisolserum levels in patients with inflammatorybowel disease. Am J Gastroenterol1998;93:2197-2202.259. Straub RH, Lehle K, Herfarth H, et al.Dehydroepiandrosterone in relation to otheradrenal hormones during an acute inflammatorystressful disease state compared withchronic inflammatory disease: role ofinterleukin-6 and tumour necrosis factor. Eur JEndocrinol 2002;146:365-367.260. Andus T, Klebl F, Rogler G, et al. Patients withrefractory Crohn’s disease or ulcerative colitisrespond to dehydroepiandrosterone: a pilotstudy. Aliment Pharmacol Ther 2003;17:409-414.261. Robinson RJ, Iqbal SJ, Al-Azzawi F, et al. Sexhormone status and bone metabolism in menwith Crohn’s disease. Aliment Pharmacol Ther1998;12:21-25.262. Lamb EJ, Wong T, Smith DJ, et al. Metabolicbone disease is present at diagnosis in patientswith inflammatory bowel disease. AlimentPharmacol Ther 2002;16:1895-1902.Alternative Medicine Review ◆ Volume 9, Number 4 ◆ 2004 Page 399Copyright©2004 Thorne Research, Inc. All Rights Reserved. No Reprint Without Written Permission